Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series

PURPOSE: To report the efficacy of intravitreal injection (IVI) of brolucizumab for recalcitrant diabetic macular edema (DME) in a real-world setting. OBSERVATIONS: This was a single-center, prospective uncontrolled non-randomized case series. Three eyes with recalcitrant DME, who have received a mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Debdulal, Sheth, Jay U., Boral, Subhendu, Sinha, Tushar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414050/
https://www.ncbi.nlm.nih.gov/pubmed/34504981
http://dx.doi.org/10.1016/j.ajoc.2021.101197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414050/
https://www.ncbi.nlm.nih.gov/pubmed/34504981
http://dx.doi.org/10.1016/j.ajoc.2021.101197

Ejemplares similares